Join
Live feed
·
INSIDERFilingvia Quantisnow
UroGen Pharma Ltd. logo

Director Holden Stuart converted options into 2,000 units of ordinary shares (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
URGN· UroGen Pharma Ltd.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track URGN (UroGen Pharma Ltd.) and more on Quantisnow.